[1]
“The Evaluation of the Glucose-Lowering Effect of Bloodletting Therapy in Type 2 Diabetes Mellitus”, Cent Asian J Med Sci, vol. 10, no. 4, pp. 140–148, Dec. 2024, doi: 10.24079/cajms.2024.04.002.